The new system integrates with the Merlin practice management system and pet owners can access the MWI Pet portal to view and book available appointments with their veterinary surgeon via any connected device.
David Tinsley, Vice President, MWI Animal Health U.K., said: “As providers continue to navigate a changing industry and evolving consumer expectations, veterinary practices need access to technologies that help them better serve the needs of both their staff and their clients.
“MWI Pet will help practices meet consumer demands for digital-driven convenience and foster deeper relationships with their clients, while freeing up more time for staff to focus on delivering high-quality care.”
To set up a demo of the new system: https://abc1.jotform.com/222564512240850
The RCVS is seeking candidates to run for election to the RCVS and VN Councils.
There are six seats on the RCVS Council and two on the VN Council due to be filled in the 2010 election. Candidate nominations must be received by 31 January 2010; voting papers will then be distributed to all veterinary surgeons and veterinary nurses eligible to vote, the election held in March and the results announced early in May. Those elected will take their seats at RCVS Day in July to serve four-year terms.
Jane Hern, RCVS Registrar said: "Like us or loathe us, what the RCVS does impacts directly on the lives of veterinary surgeons and nurses, their clients and patients. Getting regulation right is something that all Members and Listed/Registered VNs have power to influence.
"We know from the reaction we get when we propose changes or ask for your comments that vets and VNs are not backwards about coming forwards," Jane continued. "There has been a substantial rise in the number of vets voting, since a low point in voter turnout was reached in 2002. So, if you know someone you think is up to the job, why not persuade them to stand?"
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, 'manifesto' and photograph for inclusion in the elections booklets. Nobody can nominate more than one candidate, and no current member of the RCVS Council or VN Council may nominate anyone.
Newly elected RCVS Council members should expect to sit on at least one committee which, together with Council attendances, means a time commitment of at least six to eight days a year. Those elected to the VN Council should expect to spend approximately six to eight days attending Council meetings, working parties and subcommittees. Both RCVS Council and VN Council members are permitted to claim certain expenditures arising from Council-related duties and their employers can also claim a standard day-rate for loss of earnings.
Nomination forms and full details relating to RCVS Council nominations can be downloaded from www.rcvs.org.uk/rcvscouncil10 or obtained by contacting the Executive Office (020 7222 0761 or executiveoffice@rcvs.org.uk). Nomination forms and details relating to the VN Council will be online shortly at www.rcvs.org.uk/vncouncil10 and can also be requested from Annette Amato (020 7202 0788 or a.amato@rcvs.org.uk).
All nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2010.
Elanco Animal Health has announced a revision to the canine Atopica SPC, designed to provide veterinary surgeons with more flexible treatment options for canine atopic dermatitis
The updated license now states that consideration should be given to the use of other measures and/or treatments to control moderate to severe pruritus when initiating therapy with Atopica.
Elanco says pruritus control can be provided by combining Atopica with anti-inflammatory doses of prednisolone, the safety and efficacy of which has been confirmed in a clinical study1 included on the updated Atopica package leaflet.
The company says the changes to the SPC have been made in recognition of the importance of understanding the underlying cause of the itch and whilst treating dermatology cases can be a complex process, good clinical practice suggests a tailored multi-modal approach depending on the individual case. This can be done in three stages:
Alice Laurens, DVM MRCVS, dermatology marketing manager at Elanco Animal Health, said: "Dermatology cases can be difficult to treat, however the new flexible approach and the ability to combine Atopica with prednisolone will swiftly help to control pruritus in the short-term and keep the pet comfortable in the long-term."
Further information about common dermatological conditions in dogs and cats, together with a diagnostic tool are available at: www.vetassistdermatology.com.
Reference
1CPD was launched in 2020 with the aim of providing an easy-to-use platform for veterinary surgeons to use to plan, record and reflect on their continuing professional development (CPD).
The workshops, which are taking place on Wednesday 9th December 2020, are designed to help those who are not yet familiar with the platform, or have some limited experience of it but would like some additional guidance.
The first workshop takes place at midday and is for those members of the profession who haven’t yet used the platform. The session will give an overview of how 1CPD works and the benefits of using it for planning, recording and reflecting on CPD. No prior knowledge is assumed, and complete beginners are especially welcome. There'll be an opportunity to ask questions.
The second workshop takes place at 7pm and is for those who have some experience of using 1CPD but may have further questions, for example, about how to use some of its features such as the planning module and how to best make use of the reflective notes and comments feature.
Both of the workshops will last for approximately an hour each.
Susan Paterson, Chair of the RCVS Education Committee, said: “We’ve seen fantastic take up of the 1CPD platform in less than a year – with around 65% of UK-practising veterinary surgeons and an amazing 80% of veterinary nurses using it to plan, record and reflect on their professional development. The feedback that we receive has been overwhelmingly positive, with the even the more technically-challenged amongst us finding 1CPD intuitive.
"Although the numbers are very encouraging, there is a cohort of people who have not yet actively engaged with the platform and maybe are unsure about using it or are put off by the thought of having to learn how to use a brand new online system. The aim of these workshops is to guide and reassure those who are hesitant that the 1CPD system is very simple and easy-to-use with lots of useful features. In the long run, it will save you a lot of time and effort when it comes to recording your CPD because it’s there on your phone or tablet, ready to update as-and-when you need to."
Richard Burley, Chief Technology Officer for the RCVS, added: “We are very glad that the 1CPD platform developed by our team here has been so well received. We are continuing to improve and update the platform based on user feedback to improve its design and usability and would welcome any further constructive comments that members of the professions have about it. We do hope you those who are both unfamiliar with the system, and those who have used it but need further advice, can join us for these sessions to find out both how to use 1CPD and how to get the best out of it.”
To sign up to one of the workshops, visit: www.rcvs.org.uk/news-and-views/events/1cpd-online-workshop.
For those who aren’t able to make it on the day, recorded versions of all of the workshops will be made available to watch again after the event.
To download 1CPD as an app for use on iOS (Apple) or Android devices, or to access the web version, visit: www.rcvs.org.uk/1CPD
The charity reports that 2020 was its busiest year ever, with 3,921 calls to its Helpline - a 25% increase over 2019.
Similarly, Vetlife's Health Support service saw a record number of referrals in 2020. There were 190 referrals made over the year, compared to 149 in 2019.
At the same time, the charity says it has seen a decrease in income, putting a strain on its resources. The pledge from the RCVS comes in addition to the annual donation of £100,000 made by the Mind Matters Initiative towards the Health Support service. On top of this, the Mind Matters Initiative also helps to fund other essential running costs for the charity, including the Helpline call directing service and by its contribution to the annual Helpline training for volunteers.
Graham Dick, Vetlife President (pictured right) said: “The last 12 months have brought significant challenges for Vetlife as restrictions in fundraising have combined with a significant uplift in demand for our Vetlife Helpline and Health Support services. Against this background the substantial ongoing financial support provided by the RCVS through MMI, both for the costs of professional mental health support and for the necessary call-handling facilities which underpin our Helpline, continues to be an invaluable contribution to the wellbeing of the veterinary community we serve."
In addition to its Helpline service, Vetlife continued to provide mental health care through its Health Support service.
In 2023, the service facilitated 198 referrals, connecting individuals with mental health care resources.
The charity also provided over £100,000 of financial support to members of the profession who were facing financial hardship.
Trustee Danny Chambers said: "Within the veterinary community, there is a profound sense that Vetlife belongs to all of us.
"With over 4000 of our friends and colleagues reaching out for support within just 12 months, we urgently need your assistance to ensure this invaluable service continues.
"By becoming a 'Friend of Vetlife' with a monthly contribution from just £2.10—less than the cost of a cup of coffee—you provide us with a steady, predictable income, enabling us to plan and deliver long-term, consistent support to our veterinary community."
https://www.vetlife.org.uk/become-a-vetlife-member
A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new technique, which could result in a more effective, non-toxic treatment for sarcoids.
Sarcoids are skin tumors caused by infection with the Bovine Papillomavirus (BPV). They are the most common type of tumour found in horses - the estimated prevalence in the UK is 6-7%. Although the disease is rarely life threatening, many horses with sarcoids are euthanased because the condition is untreatable or because the horse is unsellable. Currently there is no universally effective treatment for sarcoids and if treatment fails the sarcoids will often come back worse.
However, research that was given funding by The Horse Trust offers a potential ray of hope for owners of horses affected by sarcoids. The research was published in Virus Research journal earlier this year.
The research, which was led by Professor Lubna Nasir of the University of Glasgow, found that by inhibiting the activity of a particular viral protein within sarcoid cells, the amount of viral DNA in the cells reduced. This led to a reduction in the growth of the sarcoid cells and caused the cell to die by Programmed cell-death (PCD). The researchers believe that PCD occurs because the sarcoid cells become reliant on the virus.
Professor Nasir said: "This could potentially be a major breakthrough in the treatment of sarcoids. We are now seeking funding to use this technique in clinical trials on horses that have sarcoids."
The research team inhibited the activity of a viral protein called E2, which is needed by BPV to replicate. They used a novel approach termed 'gene silencing' to suppress the activity of the gene that codes the E2 protein. The research was carried out in vitro on fibroblast cells, which had been cultured from sarcoid tissue removed from animals during surgery.
As this research was carried out in vitro, the researchers will now need to see if they can replicate the results in vivo, by developing a way of targeting the sarcoid cells in horses.
"One of the challenges with gene silencing is administering it within clinical setting - as you need to get molecules into every cell. As sarcoids are on the surface of a horse, we think administration should be relatively easy - potentially by injecting or applying a cream to the sarcoid," said Professor Nasir. "If we are able to successfully develop this technique it would be a non-toxic and easy to administer treatment for horses affected by this distressing condition."
Nasir's research could also have an impact on the treatment of lesions in cattle, which are also caused by BPV. Around 50% of cattle in the UK are estimated to have lesions. It may also help with the treatment of Human Papillomavirus (HPV) infections in humans. HPV, which is similar to BPV, can lead to various cancers in humans including cervical and vaginal cancer.
Paul Jepson, Chief Executive and Veterinary Director of The Horse Trust said: "We are really excited that the research we have funded could lead to a major breakthrough in the treatment of sarcoids."
The RCVS and the BVA have published the Vet Futures report: their vision for how the veterinary profession should look in 2030, coupled with 34 recommendations for change.
The report, which represents the culmination of a year of engagement, consultation and research with the veterinary profession, veterinary nurses, members of the wider veterinary team, key stakeholders, animal owners and the general public, says that in 2030 vets should be a leading force for animal health and welfare and valued for their wider roles in society. They should be confident, resilient, healthy and well supported, and benefit from exceptional leadership. And there should be a broad range of diverse and rewarding veterinary careers, as well as thriving, innovative and user-focused businesses.
While the focus of Vet Futures has been on veterinary surgeons, Vet Futures engaged with the RCVS Veterinary Nurses Council and British Veterinary Nursing Association, as well as individual veterinary nurses, and the College says that many of the ambitions should resonate with members of both professions. It goes on to recommend that the veterinary nursing profession should build on the work of Vet Futures to develop its own clear vision and ambitions.
The recommendations within the report include:
Other recommendations include developing an animal welfare strategy for the profession, increasing collaboration with medical professionals and environmental organisations, adopting a more strategic long-term outlook for research funding, and exploring how to encourage a more diverse profession.
RCVS President Bradley Viner said: "The Vet Futures report is the culmination of a year of research and engagement with thousands of members of the veterinary and veterinary nursing professions, which has given us a very firm foundation on which to build our ambitions and recommendations. We are extremely grateful to every individual who has contributed in some way to the project, and helped us to seize the initiative.
"Over the years the veterinary profession has proved itself to be adaptable and able to face challenges head on, and we have no doubt that by working together we will realise our joint vision of a profession in charge of its future. Ultimately, we all want a profession that is confident in itself and one in which members are proud to call themselves veterinary surgeons."
Sean Wensley, BVA President, added: "Vet Futures has proved to be an exciting, engaging and truly ambitious project for the veterinary profession and it has created a fantastic level of debate and engagement.
"The report we are launching today is not the end of the story; it is the beginning of the next chapter. It is crucial that we maintain the momentum of the project so we will be inviting members of the veterinary professions to step forward and join a new Vet Futures Action Group to help us turn the recommendations into actions and drive forward activity."
The full report can be downloaded here.
The procedure has already been performed in the US and Germany, where it is reported to have had a success rate of 70-80% in around 250 cases, many of which were show jumpers, eventers and dressage horses.
The team at Liphook, led by European Specialist Rachel Tucker (pictured), has now performed the procedure on six horses.
Rachel said: “Enlargement of the articular process joints of the lower neck is a relatively common finding in horses, but occasionally this can cause compression and irritation of the spinal nerves.
"The foraminotomy procedure means horses experiencing nerve pain can be made comfortable and have a good chance of returning to ridden work and a competition career.
“The surgery is minimally invasive but it is a very delicate procedure to perform because you are working very close to the spinal cord.
"Due to the location, the surgery is performed down a single portal under direct visualisation using a camera, guided by ultrasound and X-ray.
"What has been remarkable so far has been the rapid recovery of the horses, who have been home and out in a small paddock within a few days of surgery with some showing rapid signs of improved comfort and movement.
“We are very pleased with how the procedures at Liphook went.
"Our patients are continuing to recover well and we are looking forward to following their progress in the future.
https://liphookequinehospital.co.uk
Following the announcement last month of the establishment of a Working Party to review Extra-Mural Studies (EMS) in the undergraduate veterinary degree, the Royal College of Veterinary Surgeons is inviting comment from all those involved with organising, providing and receiving EMS.
Opinions are not being sought in response to a set of formal questions, but respondents may like to consider the strengths and weaknesses in the system; problems and possible solutions; and what should be retained and what could change.
Written comments should be sent to Freda Andrews, Head of Education at the RCVS, on education@rcvs.org.uk by 16 February 2009.
This call for input is the first of several phases of activity that will lead to the delivery of a report from the Working Party to the RCVS Education Policy and Specialisation Committee in October 2009. Following this initial information-gathering stage, some individuals and organisations will be invited to deliver their views in person to the Working Party during April.
Draft recommendations will then be formatted for any change to the current system, which requires that veterinary students undertake pre-clinical and clinical work experience placements for at least 38 weeks during their degree course. A further consultation process may follow, depending on the nature of the recommendations, before the paper is finalised.
Dr Barry Johnson, RCVS Council member and Chairman of the EMS Working Party said: "It is over 10 years since the RCVS undertook a major review of EMS, although the requirements and guidelines were revised and updated in 2005 to introduce more flexibility for universities to meet the individual learning needs of their students.
"In recent years, there have been significant changes in the UK higher education system, the veterinary curriculum and the organisation of veterinary schools, and the time is now right for a more substantial review."
The World Organisation for Animal Health (OIE) and the Food and Agriculture Organisation of the United Nations (FAO) have announced that today marks the declaration of the eradication of rinderpest, one of the world's most dreaded animal diseases.
The BVA likened this announcement in the history of animal health to that of the eradication of smallpox in humans.
The announcement came during the 79th General Session of the World Organisation for Animal Health (OIE), held in Paris. The global freedom status will be ratified by Ministers of Agriculture at the Food and Agriculture Organization of the United Nations (FAO) conference in June.
Rinderpest, also known as cattle plague, has ravaged cattle and the human populations that depend on them throughout history. It was rinderpest that led to the formation of the OIE in 1924 following a new incursion of the rinderpest virus in Europe, via the port of Antwerp.
Dr Peter Roeder, who was Secretary of the Global Rinderpest Eradication Programme from 2000 to 2007, said: "Once a dream, rinderpest eradication is now a reality. Not only does this magnificent achievement help to protect the livelihoods of many millions of livestock-dependent farmers but, because it removes a serious constraint to livestock trade, it has a major positive impact on many countries' economies. If we can truly learn the lessons from rinderpest eradication there is no reason why we couldn't see other diseases brought to global extinction with similar pro-poor and economic impact."
BVA President Harvey Locke added: "This monumental achievement testifies to the dedication of the veterinary services of affected countries and illustrates how vets and veterinary science can have a global impact. With that in mind I am absolutely delighted that Dr Roeder will be presenting the plenary Wooldridge Memorial Lecture at this year's BVA Annual Congress. Entitled 'Making a global Impact' Dr Roeder will discuss how vets can contribute to disease control on a global scale.
"I should also like to pay tribute to two British veterinary surgeons who made seminal contributions to the global effort to eradicate rinderpest. Gordon Scott, a rinderpest researcher, and Walter Plowright who developed the tissue culture rinderpest vaccine, were both leading lights of the rinderpest eradication effort. Sadly they are no longer with us to witness this milestone in veterinary history."
As part of the BVA's celebration of World Veterinary Year Vet2011 and to further illustrate how vets and veterinary science can have a global impact the Overseas Group is organising on Friday 23 September a full day's programme at BVA Congress: exploring current issues concerning livestock and global food security, veterinary involvement in disaster relief and management, as well as a session celebrating 100 BVA overseas travel grants.
Photograph: Rinderpest virus, copyright held by dr. Rajnish Kaushik
The questionnaire asks you about your perceptions of the PDP, with a focus on the guidance made available both by the RCVS and where applicable the resources provided by the BSAVA.
The company stresses that the survey is confidential, and results will be reported in aggregate only; no individual will be identified. It takes 5 minutes and the results will be used to help evaluate and improve the PDP in the future.
Graduates who are currently or have recently completed the PDP are invited to share their views on the PDP: http://app.keysurvey.co.uk/f/1141621/9038/
Employers / mentors of veterinary graduates are invited to share their views on the PDP here: http://app.keysurvey.co.uk/f/1141665/288d/
The event is being hosted by Luke Gamble as part of the company's ‘Advocates of Knowledge’ series, and there are £400 worth of prizes to be won:
Advocate Senior Brand Manager Vicky McAlister said: “We want to ensure that we’re delivering CPD in an engaging way, so that vets are still able to upskill in these areas, whilst also being able to engage with other vets in the industry, which is especially important given current times.
"Following the success of the first event, we’re pleased to be back again to host another and are committed to continuing to support CPD progression.”
To register for the event, visit: https://www.eventbrite.co.uk/e/113870170746
In what the company says is a European first, IVC vets will be recognised for the skills they already have, as well as supported to achieve new skills within the GP framework.
The programme is also intended to increase GP's status within the profession, boost confidence, develop ability and provide a clear path for career progression.
Edward Davies BVSc MRCVS, IVC's new Aspirational GP Lead, said: "The plethora of skills a GP vet has is unparalleled when you look at other professions.
“This programme is about recognising the core and expansive knowledge sets we as GP vets possess, not just at an individual level, but an organisational and professional level.”
An initial two cohorts of up to 20-30 vets from across the business will take part over the next 12 months, and the expectation is that it will take around two years for every cohort to complete.
The programme is structured around a portfolio-based assessment by peers, with six core and three elective categories.
The core section includes the elements seen as fundamental to being a successful GP vet, complimented by the individual vet’s selection of three elective modules which best fit their clinical interests.
IVC says it plans for the GP Vet Futures Award to be externally accredited.
If you’re a show-jumping vet, you might like to take part in the first-ever international veterinary-only riders competition – held in the beautiful region of Lure at the foot of the Vosges in France.
The French association of veterinary riders (AFVC) invites all veterinary riders to contend for the First World Veterinary Equestrian Show Jumping Cup, to be held from July 3 to 6, 2008.
The event is open to all qualified veterinarians and veterinary students, who may participate with or without their own horse.
The event will include four show-jumping competitions (one per day), while the social programme consists of a Gala evening (Friday), a dinner-dance (Saturday, sponsored by Merial) and a Sunday lunch (major sponsor of the event: Equistro / Vétoquinol).
The veterinary show-jumping event will coincide with France’s 6th Grand National show-jumping competition, also held in Lure.
For further information, please contact: David Smart DVM, david.smart@vetoquinol.com or your local Vétoquinol representative.
Virbac Animal Health has launched an enhanced version of its flea and tick spot-on Effipro (fipronil) to help pet owners master the art of 'spotonologyTM - a Maureen-Lipmanesque term the company has coined to describe the optimum application of a spot on treatment.
Effipro is now presented in a clear pipette featuring 'Drop-lock' technology to provide precise finger tip control of the flow of liquid with no risk of drip or leakage. The pipette has also been redesigned to ensure it is simple to open and that users can easily check that all the treatment has been dispensed.
Virbac says Effipro is priced to offer an effective but affordable solution to parasite control. It is presented in client packs of four pipettes and in practice packs of 24 to offer flexible dispensing opportunities. It is also available in a spray form.
Victoria Hudson, Product Manager at Virbac, said: "Parasite control is a key revenue generator for many practices. It also presents a great opportunity to create loyal, bonded clients as fleas and ticks cause great concern to pet owners.
"Effipro is already a popular product but we know that some owners find using spot-ons difficult and worry about the risk of the liquid getting on to their fingers or on furniture, particularly if their pets move around while the treatment is being applied.
"With this in mind, we've taken a fresh look at the technology of spot-ons in order to ensure that we're providing a solution which is as simple and hassle-free as possible. As a first step, we've redesigned our pipette. Our unique Drop-lock technology means that owners can start or stop the flow of liquid with their finger tips, giving them full control over where and when the product is applied. The new see-through design and enhanced opening mechanism also make the new version of Effipro more convenient to use.
"We've had great feedback from practices which have trialled the product and believe it represents a significant step forward for users of spot-ons. We are, of course, providing a range of support materials and product promotions to support its launch and look forward to working with our customers to ensure that their clients become expert and enthusiastic 'Spot.on.ologists' during 2012.
For further information about Effipro contact your Territory Manager or call Virbac on 01359 243243.
Ceva Animal Health has announced the winners of its 2014 Animal Welfare Awards. The awards recognise volunteers, charity workers and veterinary professionals who have gone the extra mile in improving animal welfare around the world. Winners were decided by a panel of industry professionals, including Christopher Laurence MBE BVSc and Claire Bessant of International Cat Care.
The winners of the 2014 Ceva Animal Welfare Awards were as follows:Christopher Laurence Vet of the Year AwardMarc Abraham, veterinary surgeon and founder of Pup Aid, for his tireless campaigning about puppy farming. He recently gathered more than the 100,000 names required to trigger a parliamentary debate about puppy farming in a record breaking six months.
Volunteer of the Year Welfare AwardJohanna Beumer from Whittingham Kennels, Essex, for dedicating the last 50 years of her life to finding loving homes for retired racing greyhounds. Joanna is one of the Retired Greyhound Trust's longest-serving volunteers.
Farm Animal Welfare AwardMolly McKay from Norfolk Farm Vets Ltd, Norfolk, for her tireless work to ensure the health and wellbeing of her farm animal patients.
Charity Professional of the YearLuke Gamble MRCVS from the Worldwide Veterinary Service, for raising awareness about animal welfare and in particular his recent work in launching Mission Rabies, a worldwide campaign to highlight this issue and bring about control.
Charity Team of the YearHope Rescue, a small charity dedicated to rescuing stray and abandoned dogs. Last year it successfully rehomed 143 dogs and on top of that placed a further 384 dogs with reputable rescues.
Welfare Nurse of the Year AwardJodie Foster from Haygate Veterinary Centre, Muxton, for her work helping owners whose pets have behavioural problems, and organising blood drives for the Pet Blood bank.
International Cat Care Welfare AwardAgnes Dufau from Plataforma Gatera for her work to ensure the welfare of cats in Spain.
Jodie Foster said: "I didn't even know I had been nominated until very recently so I'm still in shock! I'm loving every minute of the night though. Awards like these really help raise awareness of the work veterinary nurses and other veterinary professionals play in improving animal welfare."
Upon receiving their award, Vanessa Waddon of Hope Rescue, winners of the Charity Team of the Year Award, said: "We are so proud to have been recognised for all the hard work that our volunteers and one paid member of staff do. We are a very small charity, and it is amazing to have been picked as winners over hundreds of other larger charities, all deserving of awards for the fantastic work they do in animal welfare. Even though we are a small charity, we do try to make a big impact and it is wonderful that Ceva are here in recognition of the important work that smaller charities, like Hope Rescue, do."
Ceva Managing Director, Alan Doyle said: "The judging panel were overwhelmed by the quality of the entries we received this year. It is truly wonderful to read so many stories about honourable people dedicating their time to improve the welfare of animals both in the UK and internationally. The judges had a tough time whittling down the short list as there were so many well-deserved entries; however we are pleased with the final result."
Claire Bessant CEO of International Cat Care adds: "I began my charity career more than 20 years ago and I only wish awards like these one had existed then as the wonderful work that these people do needs celebrating. Ceva's Animal Welfare Awards provide a real insight into the lengths people are prepared go to improve animal welfare. The stories were both tear jerking and inspiring - each and every one deserves to be a winner."
The randomised controlled trial1 was conducted in 11 flocks with 6840 lambs during last year's lambing season (2023-2024), making it the largest ever navel protection study in the UK.
For the trial, odd numbered lambs were treated with strong iodine and even numbered lambs were treated with NoBACZ Navel.
Current practices on the farm were observed, so if the farmer normally dipped the lambs’ umbilicus they dipped with iodine or NoBACZ Navel and if they normally sprayed the umbilicus then they sprayed with iodine or NoBACZ Navel.
Survival and weights were recorded.
The study concluded that NoBACZ Navel demonstrated superior protection compared to iodine, with a 21% reduction in mortality (p=0.005).
On top of that, lambs that had NoBACZ Navel applied to the umbilicus and tagging sites were on average 230g heavier than those in the iodine group at eight weeks.
Fiona said: "Until now, best practice to manage navel ill has been to apply strong iodine to the umbilicus and ear-tagging sites by dipping or spraying to desiccate the umbilicus and disinfect the surface.
"Prophylactic antibiotic use also still occurs on as many as 19% of farms2, which is not best practice or good antimicrobial stewardship.
“NoBACZ Navel provides greater desiccation of the umbilicus than iodine and forms a non-colonisable waterproof barrier which protects lambs from the environment.
“The economic and welfare benefits to farmers are clear, with 17 more lambs alive per 1,000 born and an average of 230g extra bodyweight per lamb at eight weeks, which more than justifies the 16p per dose investment in NoBACZ Navel.
"During the trial I also received fantastic feedback from farmers on its ease of use and long-lasting protection to these vulnerable sites.”
www.nobacz.com
References
New research, conducted by the WALTHAM-initiated Laminitis Consortium, has raised questions over the assumption that soaking hay will make it safe to feed to laminitis-prone horses and ponies1.
The Laminitis Consortium comprises world-leading equine veterinary, nutrition and research experts interested in collaborating on the important topic of laminitis. It includes the authors of this work: Dr Pat Harris of the WALTHAM® Equine Studies Group, Clare Barfoot of Mars Horsecare UK Ltd and Dr Annette Longland of Equine Livestock and Nutrition Services (ELNS).
Over-consumption of water-soluble carbohydrates (WSC) has been associated with the onset of laminitis. It has been recommended that hay with a non-structural carbohydrate (WSC and starch) content of less than 10% should be fed to obese animals as well as those at risk of laminitis2 and that hay should be soaked in water before being fed in order to reduce the WSC3,4,5. The study, which was completed earlier this year, examined the loss of water-soluble carbohydrates from nine different hays submerged in water for up to 16 hours. It was presented to the biannual Equine Science Symposium in America in May 2009.
Previous studies have shown that the prolonged soaking of chopped hay in large volumes of water can result in the leaching of nutrients, including soluble carbohydrates. However, because common practice in the UK tends to involve long-stemmed hay, soaked in relatively small volumes of water over varying timescales, the Laminitis Consortium's study aimed to replicate such a practice6.
The nine different hay samples were analysed for WSC and then soaked in cold water. The soaked samples were subsequently analysed at four intervals of 20 minutes, 40 minutes, three hours and 16 hours.
Clare Barfoot said: "The results showed a highly variable leaching of WSC and substantially less leaching than reported previously for chopped hay soaked for 30 minutes.3
"Very few samples reached below 10% WSC, despite prolonged soaking. The concern is that this strongly suggests that soaking may not be sufficient to render some hays safe to feed to horses and ponies prone to laminitis.
"Our current advice is that ideally you should analyse your hay before feeding it to an animal at high risk of laminitis and choose hay with the lowest WSC content you can find. Soaking hay provides an additional safeguard but should not be relied upon."
The study also highlights that if hay is soaked for extended periods, it may not meet the nutritional requirements of the animal because substantial amounts of other nutrients, protein, vitamins and minerals will also be lost 5. In such cases it is even more important that the horse or pony should receive a balanced supplementary feed.
The Laminitis Consortium is continuing its work in this area and hopes to be able to identify practices that will be of greater benefit to the horse owner faced with hay of unknown WSC content.
1Longland AC Barfoot C & Harris PA (2009) The loss of water- soluble carbohydrate and soluble protein from nine different hays soaked in water for up to 16 hours. J. Equine Vet Science 29 (5 ) p 383 - 384, 2 Frank N Equine Metabolic Syndrome J Equine Vet Sci 29 (5) p 259 - 267, 3Cottrell, E., Watts, K., Duarte, S. and Ralston, S. (2005). Equine Science Symposium, 2005, 4Kenny, D. (2007). Proceedings of the British Society of Animal Science. 5Warr EM, Petch JL. Equine Vet Educ 1993;5:169-171, 6Longland, A.C. (2009) In preparation.
Vetsonic has announced the launch of a tablet form of Arthriaid Omega.
Designed to support joint health, the nutraceutical product contains glucosamine, chondroitin, omega 3 fatty acids, MSM, manganese sulphate plus vitamins C and E.
This new tablet form joins the existing range of palatable liquids, chews, cat gel and the original ArthriAid tablets and ArthriAid HA powder, which will continue to be available.
The increase, which was approved by the Privy Council on Thursday 2 March, will mean that the standard annual renewal fee for UK-practising veterinary surgeons (which must be paid on or before 1 April 2023) will increase by £15 to £379.
The full list of RCVS fees can be found at www.rcvs.org.uk/how-we-work/fees
Lizzie Lockett, RCVS CEO, said: “We are proud that all throughout the pandemic period, when we know that many were struggling, we managed to keep our fees at the same level in the 2020/21, 2021/22, and 2022/23 fee years.
“The increase that we proposed to the Privy Council is very modest, particularly in comparison to the overall levels of inflation that the British economy has experienced over the past year, which has had an impact on our costs.
“While we appreciate that any rise in fee levels will not be welcomed by everyone, we can assure all members of the professions that we are continuing to use our income prudently and with oversight from our Audit & Risk and Finance & Resources Committees.”
As the increase has been confirmed by the Privy Council, annual renewal fee notifications will be sent to all veterinary surgeons in early March.
As part of the University of Bristol, Langford is the only referral hospital in the South West which has an educational facility.
The new academy will also offer access to its Recent Graduate Scheme for vets that have been qualified for less than five years, advanced CPD delivered by specialists, the chance to be involved in research collaborations with Bristol Vet School, and rotating internships and residencies.
Chloe Higgins MRCVS, who is on the Recent Graduate Scheme, said: "I recently did my first splenectomy and having done the abdominal emergencies session last month, it made both the surgery and all the discussion points with the owner a lot easier and less stressful!”
For more information, email: brm@langfordvets.co.uk
The 4% increase was approved by the Privy Council and the Department for Environment, Food & Rural Affairs.
Dr Tshidi Gardiner, RCVS Treasurer, said: “As with last year, RCVS Council recognises that we are living in difficult economic times, and have tried to keep the fee increase to a minimum.
"However, it is important that we increase fees in line with inflation, as well as take into account additional related costs, to ensure we are fulfilling our regulatory remit to the best of our abilities and meet our strategic priorities.”
Veterinary surgeons need to pay their annual renewal by 1st April and will be sent their fee notices within the first two weeks of March.
Anyone who has not paid their fee by 1st May will incur a higher fee charge of £36, with non-payment by 1st June risking removal from the Register and ineligibility to practise.
As part of the annual renewal process, all individual vets will also need to log into their online MyAccount to confirm their registration and contact details and declare any convictions.
Anyone who expects to encounter any difficulties in paying their fees should contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
Novartis Animal Health has announced that it will begin marketing and distributing Adequan Equine in the UK from January 2011.
According to the company, Adequan Equine offers equine veterinarians a proven intramuscular treatment option for equine degenerative joint disease, also known as non-infectious arthritis or osteoarthritis. The product is licensed in the UK for the treatment of lameness in horses due to traumatic or degenerative aseptic joint disease and acute superficial digital flexor tendonitis. This is a critical treatment area since equine degenerative joint disease is estimated to cause up to one-third of all equine lameness cases1. It most commonly affects the hocks and coffin joints with the most severe effects on the high-motion knee and fetlock joints.
Esther Rawlinson MRCVS, Global Technical Services Manager for the Novartis Animal Health Companion Animal Business in the Therapeutics & Equine areas said: "Adequan Equine is a leading joint treatment for horses and is widely used by veterinarians in the equine sport industry. Adequan Equine reduces pain and lameness in horses while at the same time stimulating cartilage repair.
Adequan Equine 100mg/ml solution contains polysulphated glycosaminoglycan for intramuscular injection. It is a chondroprotective, meaning it inhibits the breakdown of cartilage in diseased joints while at the same time supporting its repair.
Adequan Equine works by blocking the destructive enzymes formed in the joint as a result of inflammation while stimulating the production of hyaluronic acid to restore the synovial fluid, and the synthesis of cartilage building compounds.
Merial has announced the UK launch of updated ProteqFlu, the first and only EI vaccine in Europe to contain a clade 2 strain.
The company says the new vaccine is also the only one that is fully compliant with the latest 2014 OIE recommended EIV strains.
Louise Radford MRCVS from Merial said: "The launch marks the UK's first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen which includes protection against the latest Florida Clade 2 strain, Richmond 07. This is a significant step for horse health, and the equine industry as a whole."
Hervé Poulet, Merial's head of BioDevelopment and BioResearch said: "Merial has developed strong and unique expertise in the development of non-replicative recombinant canarypox virus-vectored vaccines for various species and diseases.
"For the development of ProteqFlu, our non-replicative recombinant canarypox vector expressing the EI virus haemagglutinin (HA) is used because of its ability to induce a strong cellular immunity which is an essential component in protecting against this highly contagious disease."
Louise added: "ProteqFlu has also demonstrated its success and efficacy in real outbreaks, particularly during the last major outbreak, in Australia in 2007. ProteqFlu was the only vaccine chosen for the eradication programme."